Vaxart Inc.
Get Full AccessDescription
- Vaxart is a clinical-stage company developing tablet vaccines based on its proprietary oral vaccine platform. The lead programs are oral vaccines for seasonal influenza, RSV and Norovirus. Vaxart vaccines are convenient room temperature-stable tablets that can be stored and shipped without refrigeration, are easy to administer, eliminate risk of needle-stick injury and medical waste associated with injectable vaccines. The company is backed by Care Capital, Finney Capital, Quantum Technology Partners, Life Science Angels, Sand Hill Angels and Bay Partners.
-
Headquarters:290 Utah Avenue , South San Francisco, California, United States
More -
Phone Number: +1 650-550-3500
-
Website: https://vaxart.com/
-
Employees:27
-
Revenue:$10 - 50M
-
Legal Name:Vaxart Inc.
-
Vaxart Inc.'s Social Media
-
Is this data correct?
-
| NAICS Code: 541713 |
Show More
Sell more in less time!
Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!
Frequently Asked Questions regarding Vaxart Inc.
-
Where are Vaxart Inc.'s Headquarters?
Vaxart Inc.'s Headquarters are in 290 Utah Avenue ,South San Francisco,California,United States
-
What is Vaxart Inc.'s phone number?
Vaxart Inc.'s phone number is +1 650-550-3500
-
What is Vaxart Inc.'s official website?
Vaxart Inc.'s official website is https://vaxart.com/
-
What is Vaxart Inc.'s Revenue?
Vaxart Inc.'s revenue is $10 - 50M
-
What is Vaxart Inc.'s NAICS code?
Vaxart Inc.'s NAICS code is 541713
-
How many employees are working in Vaxart Inc.
Vaxart Inc. has 27 employees
-
What is Vaxart Inc.'s Industry?
Vaxart Inc. is in the industry of Biotechnology
-
Who is Vaxart Inc.'s CEO?
Vaxart Inc.'s CEO is Andrei Floroiu